Abivax has announced the appointment of James Berger as Global Head of Marketing. With over 20 years of experience in the biopharmaceutical industry, he will lead the company's commercial strategy and brand development.
Company Information
Company
Abivax
Location
Rue De La Baume
Paris, Ile-de-France, France
About
Abivax is developing therapies that modulate the body’s natural immune system machinery. A clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to develop drug candidates to treat inflammatory diseases, viral diseases and liver cancer. Abivax is based on innovative research driven by the idea of modulating the body’s natural immune system mechanisms to treat diseases.
Don't miss Abivax's next move
Get an email the moment Abivax changes its leadership, hires an exec, or expands, usually minutes after it happens.